CONMED Corporation
CONMED Corporation (CNMD) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CNMD · as of Sep 30, 2024
Ownership Breakdown
298
Institutional Holders
▼ 2 vs Q2
$2.44B
Total Inst. Value
▼ $34.75M vs Q2
30.11M
Shares Outstanding
freeFloat 99.58%
33.93M
13F Shares Held
▼ 1.78M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CNMD largest shareholders · institutional ownership
Q3 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. electromedical & electrotherapeutic apparatus | 4.99M | 16.19% | 16.19% | $359.23B | Nov 13, 2024 | NEW |
VANGUARD GROUP INC electromedical & electrotherapeutic apparatus | 3.53M | 11.44% | 11.44% | $253.85B | Nov 13, 2024 | ▲ 43.9K |
EARNEST PARTNERS LLC electromedical & electrotherapeutic apparatus | 2.78M | 9.02% | 9.02% | $200.25B | Nov 14, 2024 | ▼ 34.3K |
CAPITAL RESEARCH GLOBAL INVESTORS electromedical & electrotherapeutic apparatus | 1.54M | 5.01% | 5.01% | $111.08B | Nov 13, 2024 | ▼ 164.9K |
BANK OF AMERICA CORP /DE/ electromedical & electrotherapeutic apparatus | 1.37M | 4.44% | 4.44% | $98.55B | Nov 14, 2024 | ▲ 46.7K |
CHAMPLAIN INVESTMENT PARTNERS, LLC electromedical & electrotherapeutic apparatus | 1.37M | 4.43% | 4.43% | $98.36B | Nov 12, 2024 | ▲ 82.0K |
STATE STREET CORP electromedical & electrotherapeutic apparatus | 1.31M | 4.24% | 4.24% | $94.28B | Nov 14, 2024 | ▲ 54.9K |
MACQUARIE GROUP LTD electromedical & electrotherapeutic apparatus | 935.6K | 3.03% | 3.03% | $67.29B | Nov 14, 2024 | ▲ 41.2K |
WESTWOOD HOLDINGS GROUP INC electromedical & electrotherapeutic apparatus | 882.1K | 2.86% | 2.86% | $63.44B | Nov 14, 2024 | ▲ 33.4K |
SEI INVESTMENTS CO electromedical & electrotherapeutic apparatus | 870.7K | 2.82% | 2.82% | $62.62B | Nov 12, 2024 | ▼ 17.3K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2024 vs prior quarter
Q3 2024
28
Increased
+1.04M shares1
New Positions
first time holders21
Decreased
−1.12M shares0
Sold Out
fully exitedNet shares change (top 50)
74.3K
+1.04M / −1.12M
Net new holders
+8
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CNMD insider trading · insider activity
Source: SEC Form 4
1
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Beyer Pat President & CEO | Apr 1, 2026 | Award | 28,145 | — | — | 28.1K | Form 4 ↗ |
Lalomia Brent Executive VP RA, QA | Mar 2, 2026 | Award | 17,198 | — | — | 17.2K | Form 4 ↗ |
Schabacker Matthew VP GM Advanced Surgical | Mar 2, 2026 | Award | 17,471 | — | — | 17.5K | Form 4 ↗ |
Foust Hollie K General Counsel & Corp Sec | Mar 2, 2026 | Award | 18,563 | — | — | 18.6K | Form 4 ↗ |
Ferrell John D. Executive Vice President - HR | Mar 2, 2026 | Award | 16,926 | — | — | 16.9K | Form 4 ↗ |
SHAGORY PETER K EVP, STRAT & CORP DEVT | Mar 2, 2026 | Award | 16,926 | — | — | 16.9K | Form 4 ↗ |
Lalomia Brent Executive VP RA, QA | Mar 6, 2026 | Tax Withhold | 26 | $39.90 | $1.0K | 915.057 | Form 4 ↗ |
Schabacker Matthew VP GM Advanced Surgical | Mar 2, 2026 | Award | 11,646 | $45.79 | $533.3K | 11.6K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
CONMED Corporation (CNMD) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 0.42%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of CONMED Corporation is BLACKROCK, INC., holding approximately 4.99 million shares — equal to 16.19% of outstanding shares — as of September 30, 2024.
A total of 298 institutional investors currently hold CNMD stock, with a combined institutional value of approximately $2.44 billion as of the most recent 13F filing period.
Frequently asked questions
CNMD ownershipCONMED Corporation (CNMD) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is BLACKROCK, INC. with a 16.19% stake. Company insiders hold 0.42%. Data sourced from SEC Form 13F as of September 30, 2024.